|
Registration
Information |
|
Full Day |
$50 for a full day
(lunch included) for pre-registration prior to
October 15th |
|
Half Day |
$30 for a half day
for pre-registration prior to October 15th. |
|
Late Fee |
$10 late fee
will be applied to anyone who registers after
October 15th
or at the door. |
|
Registration Form |
Click here to access the Attendee
Registration Form |
|
Questions? |
Edwina Szelag
at
(321) 434-5249
Edwina.Szelag@health-first.org
|
| |
Kay Fergason at 904-282-9040
flakaylab@yahoo.com
|
|
October 28th Roundtable |
|
7:00 - 9:00 pm |
How to
meet the 6 elements of competency for non
waived testing (New Cap std) =
Point
of Care Roundtable session
This
discussion will focus on the six elements
included in the CAP checklists
and in CLIA: 1. Direct Observation of
testing; 2. Monitoring of test reporting; 3.
Review of testing records; 4. Direct
Observation of Maintenance and Function
Checks; 5. Proficiency and Blind Sample
testing; and 6. Problem Solving Skills.
There will be no CE credits awarded. We have arranged space at
the hotel’s restaurant “THE U” on Thursday
evening at 7pm for this dinner session. This is separate from
the conference programming and everyone will
need to pay their own meal expenses. Please check
the bottom of your pre-registration form if
you wish to be included. |
|
October 29th Program |
|
7:30 am –
1:30 pm |
REGISTRATION |
|
8:00 am –
8:50 am
(1 contact hour) |
1. TURMOIL IN THE
BUSINESS OF BLOOD BANKING
Discussion will focus on the rapidly
changing blood industry; an explanation of
why the day of Immunohematology the
independent blood center is in the past; a
crystal ball look at the future with regard
to expected changes in business practices,
services and blood safety initiatives;
hemovigilance programs and current efforts
to reduce blood utilization.
MIKE
PRATT, BS, MS, MT(ASCP)SBB, COO and Interim
CEO, Florida Blood Centers, Orlando |
|
8:00 am – 9:50 am
(2
contact hours)
Supv.
/ Admin. |
2. CULTURAL
DIVERSITY – GENERATIONS AT WORK
Residing
in Florida, we live in a multicultural hub.
Cultural beliefs influence the response of
General patients and family members to
illness or medical procedures and may even
interfere with the healing process itself.
The last thing you want to do is offend a
patient, his or her family or even a
co-worker. Body gestures have different
meanings according to the country in which
they are expressed. Learn when eye contact,
smiling, handshaking, etc. is appropriate
and how much family involvement is
customary. In addition, age ranges of
employees have vastly changed over the
years. Many retirees have returned to the
work force. Different age groups have
different expectations, concerns, work
ethics, etc. Understanding these differences
promotes a better work environment and
communication, which is vital in delivering
quality healthcare.
CAROLINA
ALVARADO, BSMT H(ASCP), CPT(ASPT),
Laboratory Education, Florida Hospital,
Orlando |
|
9:00 am – 9:50 am
(1 contact hour) |
3. INFECTIOUS
DISEASE TESTING AT THE POINT OF CARE
Antigen/antibody detection, molecular
testing and other systems have transformed
clinical Microbiology microbiology from a
confirmatory to a diagnostic service. As
these methods mature, they have the
potential to move ever closer to the point
of care. This presentation will review
current systems for infectious disease point
of care testing and evaluate future
priorities and possibilities.
PAUL
YATES, BS, DLM(ASCP), CIC(CBIC), Infection
Control Manager, Health First, Inc., Holmes
Regional Medical Center, Melbourne |
|
9:50 am –
10:20 am |
COFFEE /
DONUT BREAK -
VISIT
WITH YOUR EXHIBITORS |
|
10:20
am – 11:10 am (1 contact hour) |
4.
GLUCOSE TESTING IN
ACUTE AND CHRONIC CARE FACILITIES
FDA and
Standards groups are currently in the
process of updating the guidelines for blood
glucose Chemistry monitors. The purpose of
this presentation is to provide an update on
the proposed content of revised guidances
and a review of areas of controversy.
Appropriate use and limitations of point of
care blood glucose testing systems and
infection control will also be discussed.
RICK
LEBO, BS, MT(ASCP), Manager Customer
Technical Services, Eastern Region
LifeScan,
Inc. a Johnson & Johnson Company |
|
10:20 am –
11:10 am (1
contact hour) |
5.
HEMOSTASIS UPDATE
A review
of the original coagulation cascade and
comparison to the latest theories of blood
Hematology coagulation.
DORILYN
HITCHCOCK, MS, MT (ASCP), Assistant
Professor of Medicine
Director,
Medical Laboratory Sciences; Coordinator,
Molecular Biology, Central Florida
University, Orlando |
|
11:20 am – 12:10 pm (1 contact hour) |
6. QUALITY CONTROL
BASED ON RISK MANAGEMENT
This
session will explore common errors that
occur when conducting point of care testing
and Supv. / Admin. identify quality control
features that can be engineered into devices
to prevent errors. New CLSI guidelines for
developing quality control plans based on
risk management.
JAMES H.
NICHOLS, Ph.D., DABCC, FACB, Professor of
Pathology, Tufts University School of
Medicine, Medical Director, Clinical
Chemistry, Baystate Health, Springfield,
Mass. Sponsored by INTERNATIONAL TECHNIDYNE
CORPORATION |
|
11:20 am – 12:10 pm( 1
contact hour) |
7. NEW ERA FOR
HORMONE TESTING
“The Women’s Initiative Study” caused
millions of women and Doctors to quit
Hormone
Chemistry Replacement Therapy. Was
something faulty? What is the replacement?
Oprah, Dr. Phil and Suzanne Sommers are
leading a charge of new awareness that is at
a grass roots level. Bioidenticals – And it
is BIG.
GREGORY RAWLING, AHI(AMT), SC(ASCP)MT,
Consultant, Delray Beach |
|
12:10 pm – 1:00 pm |
LUNCH (included) -
VISIT WITH YOUR EXHIBITORS |
|
1:00 pm – 2:20 pm (1.5 contact hours)
Supv.
/ Admin. |
8. DEVELOPING THE
SUCCESSFUL BUSINESS CASE TO LEAD LABORATORY
CHANGE
This
presentation will develop in detail the
essential elements of the business case to
include required Supporting Documentation .
Examples of successful clinical laboratory
business cases will be reviewed. Procedures
will be identified for calculating business
case financial parameters such as NPV, ROI
and
payback
periods. This workshop will be the basis for
a second certificate, Laboratory Finances,
in laboratory management offered by the AACC
Management Sciences Division.
LEROY
MELL, PhD, MBA, HCLD (AAB), Clinical
Laboratory Director, Integrated Regional
Laboratories, Ft. Lauderdale |
|
1:00 pm – 2:20 pm (1.5 contact hours) |
9. STEM CELLS,
When did they appear on the horizon?
Stem cell
transplantation; definition of a stem cell;
stem cell types; clinical applications
Hematology and secondary insights to cancer
biology.
MARCO
BURENKO, MD, FCAP, FASCP, Medical Laboratory
Director, Cape Canaveral Hospital, Cape
Canaveral/Cocoa |
|
2:20 pm – 2:40 pm |
REFRESHMENT BREAK -
VISIT WITH YOUR EXHIBITORS |
|
2:40 pm – 3:30 pm (1 contact hour) |
10. HIV / AIDS
UPDATE
Difference between being HIV positive and
actually being diagnosed with AIDS; modes of
HIV /AIDS transmission; prevention; testing;
workplace exposure protocols; treatment;
claims of possible cure, etc.
Karen
Kelly, MT (ASCP), Microbiology Supervisor,
Watson Clinic, Lakeland |
|
2:40 pm – 3:30 pm
(1
contact hour)
Molecular |
11. IMPACT OF
MOLECULAR DIAGNOSTIC TESTING – REAL TIME
PCR TECHNOLOGIES
Molecular
diagnostic testing provides innovative
solutions to today’s clinical challenges.
This presentation will provide an overview
of molecular technologies and specific
examples of how molecular diagnostic testing
is having a positive impact on patient
healthcare.
JOHN OSIECKI,
Ph.D., Manager, Medical and Scientific
Affairs, Roche Diagnostics, Indianapolis,
Ind. Sponsored by ROCHE MOLECULAR |
|
Continuing
Education Credits |
|
Provider |
STATE
OF FLORIDA CE BROKER Provider: # 50 – 2288 |
|
Provider |
AMERICAN MEDICAL TECHNOLOGISTS INSTITUTE
FOR EDUCATION : # 823307 |
|
Vendor Opportunities |
|
Vendor
Space |
Purchase of vendor
space (click
here for the vendor form) |
|
Sponsorships |
Sponsorship
of break or lunch (contact Edwina Szelag at
(321) 434-5249
Edwina.Szelag@health-first.org or Kay
Fergason at 904-282-9040
flakaylab@yahoo.com for more information). |
